The Italian Competition Authority opens investigation against pharmaceutical companies over suspected cartel activity in the ophthalmologic medicines market (Roche / Novartis)

L'Ecluse, Peter

Previous article The Italian Competition Authority launches an investigation against pharmaceutical companies suspected of restricting drug sales (Roche / Novartis) Next article The Swedish Competition Authority requires payment of procurement fines for signing an agreement as regards rental of printers, scanners and copying machines without public procurement (Karolinska institutet)

6 Feb 2013

The Italian Competition Authority opens investigation against pharmaceutical companies over suspected cartel activity in the ophthalmologic medicines market (Roche / Novartis)

KEYWORDS

Reference

Italian Competition Authority, Roche / Novartis, 6 February 2013 (Italian)

On 14 February 2013, the Italian Competition Authority (the “Authority”) announced that it had opened an investigation against Genentech Inc., Hoffmann-La Roche Ltd, Novartis AG, Novartis Farma S.p.A. and Roche S.p.A., over suspicions that these may have been operating an illegal cartel in the

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Peter L’Ecluse
Van Bael & Bellis (Brussels)

Belgium 125 contributions 35645 visits

Quotation

Peter L'Ecluse, The Italian Competition Authority opens investigation against pharmaceutical companies over suspected cartel activity in the ophthalmologic medicines market (Roche / Novartis), 6 February 2013, e-Competitions February 2013, Art. N° 58204

Visites 248